Onconova Therapeutics, Inc.·4

Nov 26, 7:46 AM ET

OLER ABRAHAM N. 4

4 · Onconova Therapeutics, Inc. · Filed Nov 26, 2019

Insider Transaction Report

Form 4
Period: 2019-11-25
OLER ABRAHAM N.
VP Corp Dev & Gen Counsel
Transactions
  • Purchase

    Warrant (right to purchase)

    2019-11-25+75,00075,000 total
    Exercise: $0.20From: 2019-11-25Exp: 2024-11-25Common Stock (75,000 underlying)
  • Purchase

    Common Stock

    2019-11-25$0.20/sh+75,000$15,00075,000 total
Footnotes (1)
  • [F1]The common stock and warrants were acquired in a public offering, by Onconova Therapeutics, Inc, of units which included one share of common stock and one warrant. The public offering price for each unit was $0.20.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -